Showing results (91-100 of 119) with videos related to
Sort By:
Pageof 12
Vascular Medicine (London, England)|July 17, 1998
Forearm blood flow measured by venous occlusion plethysmography in healthy subjects and in women with postmastectomy oedemaA W Stanton, B Holroyd, J W Northfield, et al.Pulmonary Pharmacology|January 1, 1990
The generation and metabolism of leukotrienes in the ionophore-stimulated blood of normal and asthmatic subjectsA P Sampson, J M Evans, L G Garland, et al.Thorax|June 1, 1991
Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in manD A Spencer, J M Evans, S E Green, et al.Agents and Actions|December 1, 1980
Slow-reacting substances and their formation by a lipoxygenase pathwayP J Piper, M N Samhoun, J R Tippins, et al.Ciba Foundation Symposium|January 1, 1980
Slow-reacting substances and their structural elucidationP J Piper, M N Samhoun, J R Tippins, et al.Prostaglandins|February 1, 1980
Slow reacting substances (SRSs): the structure identification of SRSs from rat basophil leukaemia (RBL-1) cellsH R Morris, G W Taylor, P J Piper, et al.British Journal of Clinical Pharmacology|December 1, 1990
Leukotrienes in the sputum and urine of cystic fibrosis childrenA P Sampson, D A Spencer, C P Green, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 1, 1990
Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal manD A Spencer, S E Green, J M Evans, et al.FEBS Letters|October 1, 1984
PHI-like immunoreactivity in the gallbladder and in vitro effect of porcine PHI on smooth muscle of the gallbladderY Yiangou, N D Christofides, J Gu, et al.Circulation|July 1, 1994
Preferential vasoconstriction to cysteinyl leukotrienes in the human saphenous vein compared with the internal mammary artery. Implications for graft performanceS P Allen, A H Chester, M R Dashwood, et al.Pageof 12